The effect of CFTR modulators on CF-related sinonasal disease was analyzed for ivacaftor in several low-quality studies, and for combined triple therapy based on elexacaftor, tezacaftor, and ivacaftor in two independent investigations. Here, CFTR is linked to cystic fibrosis.